143 related articles for article (PubMed ID: 38701687)
1. Navigating through the coordination preferences of heavy alkaline earth metals: Laying the foundations for
Franchi S; Madabeni A; Tosato M; Gentile S; Asti M; Orian L; Di Marco V
J Inorg Biochem; 2024 Jul; 256():112569. PubMed ID: 38701687
[TBL] [Abstract][Full Text] [Related]
2. Reining in Radium for Nuclear Medicine: Extra-Large Chelator Development for an Extra-Large Ion.
Simms ME; Sibley MM; Driscoll DM; Kertesz V; Damron JT; Ivanov AS; White FD; Thiele NA
Inorg Chem; 2023 Dec; 62(50):20834-20843. PubMed ID: 37811965
[TBL] [Abstract][Full Text] [Related]
3. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
4. Sub-10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy.
Reissig F; Zarschler K; Hübner R; Pietzsch HJ; Kopka K; Mamat C
ChemistryOpen; 2020 Aug; 9(8):797-805. PubMed ID: 32775141
[TBL] [Abstract][Full Text] [Related]
5. Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine.
Whetter JN; Śmiłowicz D; Boros E
Acc Chem Res; 2024 Mar; 57(6):933-944. PubMed ID: 38501206
[TBL] [Abstract][Full Text] [Related]
6. A comparative evaluation of calix[4]arene-1,3-crown-6 as a ligand for selected divalent cations of radiopharmaceutical interest.
Bauer D; Blumberg M; Köckerling M; Mamat C
RSC Adv; 2019 Oct; 9(55):32357-32366. PubMed ID: 35530789
[TBL] [Abstract][Full Text] [Related]
7.
Jadvar H; Colletti PM
Br J Radiol; 2018 Nov; 91(1091):20170948. PubMed ID: 29630398
[TBL] [Abstract][Full Text] [Related]
8. Chelating Rare-Earth Metals (Ln
Hu A; Simms ME; Kertesz V; Wilson JJ; Thiele NA
Inorg Chem; 2022 Aug; 61(32):12847-12855. PubMed ID: 35914099
[TBL] [Abstract][Full Text] [Related]
9. Tuning the Kinetic Inertness of Bi
Fiszbein DJ; Brown V; Thiele NA; Woods JJ; Wharton L; MacMillan SN; Radchenko V; Ramogida CF; Wilson JJ
Inorg Chem; 2021 Jun; 60(12):9199-9211. PubMed ID: 34102841
[TBL] [Abstract][Full Text] [Related]
10. The Curies' element: state of the art and perspectives on the use of radium in nuclear medicine.
Franchi S; Asti M; Di Marco V; Tosato M
EJNMMI Radiopharm Chem; 2023 Nov; 8(1):38. PubMed ID: 37947909
[TBL] [Abstract][Full Text] [Related]
11. Radium-223 in the treatment of osteoblastic metastases: a critical clinical review.
Humm JL; Sartor O; Parker C; Bruland OS; Macklis R
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):898-906. PubMed ID: 25832684
[TBL] [Abstract][Full Text] [Related]
12. Alkaline earth metal catalysts for asymmetric reactions.
Kobayashi S; Yamashita Y
Acc Chem Res; 2011 Jan; 44(1):58-71. PubMed ID: 20979379
[TBL] [Abstract][Full Text] [Related]
13. Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.
Notni J; Šimeček J; Wester HJ
ChemMedChem; 2014 Jun; 9(6):1107-15. PubMed ID: 24700633
[TBL] [Abstract][Full Text] [Related]
14. Radiometal complexes in molecular imaging and therapy.
Rey AM
Curr Med Chem; 2010; 17(31):3673-83. PubMed ID: 20846111
[TBL] [Abstract][Full Text] [Related]
15.
Li L; Rousseau J; Jaraquemada-Peláez MG; Wang X; Robertson A; Radchenko V; Schaffer P; Lin KS; Bénard F; Orvig C
Bioconjug Chem; 2021 Jul; 32(7):1348-1363. PubMed ID: 32216377
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([
Diniz Filho JFS; de Barros AODS; Pijeira MSO; Ricci-Junior E; Midlej V; Baroni MPMA; Dos Santos CC; Alencar LMR; Santos-Oliveira R
Cells; 2023 Jan; 12(3):. PubMed ID: 36766793
[TBL] [Abstract][Full Text] [Related]
17. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results.
Trencsényi G; Csikos C; Képes Z
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203834
[TBL] [Abstract][Full Text] [Related]
18. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
Cheetham PJ; Petrylak DP
Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
[TBL] [Abstract][Full Text] [Related]
19. Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy.
Hagemann UB; Wickstroem K; Hammer S; Bjerke RM; Zitzmann-Kolbe S; Ryan OB; Karlsson J; Scholz A; Hennekes H; Mumberg D; Cuthbertson AS
Cancer Biother Radiopharm; 2020 Sep; 35(7):497-510. PubMed ID: 32255671
[TBL] [Abstract][Full Text] [Related]
20. Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.
Patel CM; Wadas TJ; Shiozawa Y
Molecules; 2021 Apr; 26(8):. PubMed ID: 33918705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
